Showing 1 - 4 results of 4 for search 'C. Arsov', query time: 0.02s Refine Results
  1. 1
    Risk stratification based on size of equivocal PI-RADS lesions may safely reduce the number of MRI-targeted biopsies

    Risk stratification based on size of equivocal PI-RADS lesions may safely reduce the number of MRI-targeted biopsies by D.F. Osses, C. Arsov, L. Schimmöller, P. Albers, M.J. Roobol

    Published 2020-07-01
    Get full text
    Article
  2. 2
    Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate

    Single center analysis of an advisable control interval for follow-up of patients with PI-RADS category 3 in multiparametric MRI of the prostate by M. Boschheidgen, L. Schimmöller, S. Doerfler, R. Al-Monajjed, J. Morawitz, F. Ziayee, D. Mally, M. Quentin, C. Arsov, P. Albers, G. Antoch, T. Ullrich

    Published 2022-04-01
    Get full text
    Article
  3. 3
    Data on the detection of clinically significant prostate cancer by magnetic resonance imaging (MRI)-guided targeted and systematic biopsy

    Data on the detection of clinically significant prostate cancer by magnetic resonance imaging (MRI)-guided targeted and systematic biopsy by M Klingebiel, C Arsov, T Ullrich, M Quentin, R Al-Monajjed, D Mally, LM Sawicki, A Hiester, I Esposito, P Albers, G Antoch, L Schimmöller

    Published 2022-12-01
    Get full text
    Article
  4. 4
    Effect of sexual behavior on prostate-specific antigen levels in middle-aged men screened for prostate cancer: Results from the PROBASE trial

    Effect of sexual behavior on prostate-specific antigen levels in middle-aged men screened for prostate cancer: Results from the PROBASE trial by V.H. Meissner, M. Hollerer, M. Kron, S. Schiele, P. Albers, C. Arsov, M. Kuczyk, F. Imkamp, M. Hohenfellner, V. Schütz, J.E. Gschwend, K. Herkommer

    Published 2020-07-01
    Get full text
    Article

Search Tools: